Last 12 months
Inside the activity.
1 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Hait WilliamSee Remarks
|
Tax withholdingCommon Stock | 427 | $157.85 | $67,401.95 |
DisclosureSEC source: 0001225208-24-002178 · doc4.xml · nonDerivative · entry 2 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,647 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionCommon Stock | 834 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002178 · doc4.xml · nonDerivative · entry 1 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,074 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionRestricted Share Units · Derivative | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002179 · doc4.xml · derivative · entry 5 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 998 Underlying: Common Stock · 499 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 250 | $157.85 | $39,462.50 |
DisclosureSEC source: 0001225208-24-002179 · doc4.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,040 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 499 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002179 · doc4.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionRestricted Share Units · Derivative | 447 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002180 · doc4.xml · derivative · entry 3 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 894 Underlying: Common Stock · 447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Swanson James D.EVP, CIO
|
Tax withholdingCommon Stock | 195 | $157.85 | $30,780.75 |
DisclosureSEC source: 0001225208-24-002180 · doc4.xml · nonDerivative · entry 2 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,570 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionCommon Stock | 447 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002180 · doc4.xml · nonDerivative · entry 1 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionRestricted Share Units · Derivative | 1,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002181 · doc4.xml · derivative · entry 3 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,604 Underlying: Common Stock · 1,302 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Tax withholdingCommon Stock | 666 | $157.85 | $105,128.10 |
DisclosureSEC source: 0001225208-24-002181 · doc4.xml · nonDerivative · entry 2 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 154,851.001 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionCommon Stock | 1,302 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002181 · doc4.xml · nonDerivative · entry 1 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,517.001 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionRestricted Share Units · Derivative | 1,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002182 · doc4.xml · derivative · entry 4 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,558 Underlying: Common Stock · 1,780 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Wolk Joseph JExec VP, CFO
|
Tax withholdingCommon Stock | 773 | $157.85 | $122,018.05 |
DisclosureSEC source: 0001225208-24-002182 · doc4.xml · nonDerivative · entry 2 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,890 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Wolk Joseph JExec VP, CFO
|
Exercise / conversionCommon Stock | 1,780 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002182 · doc4.xml · nonDerivative · entry 1 Wolk Joseph J · CIK 0001744564 · Exec VP, CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,663 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionRestricted Share Units · Derivative | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002183 · doc4.xml · derivative · entry 5 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,302 Underlying: Common Stock · 651 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.exercise_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 333 | $157.85 | $52,564.05 |
DisclosureSEC source: 0001225208-24-002183 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,265.8735 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2024 Filed Feb 15, 2024 21:53 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 651 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002183 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,598.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The Restricted Share Units awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The Restricted Share Units converted into shares of Common Stock upon vesting. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionPerformance Share Units · Derivative | 11,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002095 · doc4.xml · derivative · entry 6 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,826 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Tax withholdingCommon Stock | 7,066 | $157.40 | $1,112,188.40 |
DisclosureSEC source: 0001225208-24-002095 · doc4.xml · nonDerivative · entry 3 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,947.8735 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 1,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002095 · doc4.xml · nonDerivative · entry 2 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,013.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Wengel Kathryn EEVP, Chief TO and Risk Officer
|
Exercise / conversionCommon Stock | 11,826 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002095 · doc4.xml · nonDerivative · entry 1 Wengel Kathryn E · CIK 0001745955 · EVP, Chief TO and Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,026.8735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionPerformance Share Units · Derivative | 1,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002096 · doc4.xml · derivative · entry 6 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,637 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Decker Robert JVP Corporate Controller
|
Tax withholdingCommon Stock | 523 | $157.40 | $82,320.20 |
DisclosureSEC source: 0001225208-24-002096 · doc4.xml · nonDerivative · entry 3 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,746 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 275 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002096 · doc4.xml · nonDerivative · entry 2 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Decker Robert JVP Corporate Controller
|
Exercise / conversionCommon Stock | 1,637 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002096 · doc4.xml · nonDerivative · entry 1 Decker Robert J · CIK 0001798703 · VP Corporate Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionPerformance Share Units · Derivative | 31,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002097 · doc4.xml · derivative · entry 5 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,351 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Tax withholdingCommon Stock | 15,900 | $157.40 | $2,502,660.00 |
DisclosureSEC source: 0001225208-24-002097 · doc4.xml · nonDerivative · entry 3 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 361,339 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 5,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002097 · doc4.xml · nonDerivative · entry 2 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,239 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Duato JoaquinDirector · CEO and Chairman of the Board
|
Exercise / conversionCommon Stock | 31,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002097 · doc4.xml · nonDerivative · entry 1 Duato Joaquin · CIK 0001673401 · Director · CEO and Chairman of the Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionPerformance Share Units · Derivative | 12,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002098 · doc4.xml · derivative · entry 4 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,808 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Tax withholdingCommon Stock | 7,019 | $157.40 | $1,104,790.60 |
DisclosureSEC source: 0001225208-24-002098 · doc4.xml · nonDerivative · entry 3 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,625 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 2,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002098 · doc4.xml · nonDerivative · entry 2 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Fasolo PeterExec VP, Chief HR Officer
|
Exercise / conversionCommon Stock | 12,808 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002098 · doc4.xml · nonDerivative · entry 1 Fasolo Peter · CIK 0001509999 · Exec VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionPerformance Share Units · Derivative | 2,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002099 · doc4.xml · derivative · entry 4 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,448 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Tax withholdingCommon Stock | 1,034 | $157.40 | $162,751.60 |
DisclosureSEC source: 0001225208-24-002099 · doc4.xml · nonDerivative · entry 3 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,925 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionCommon Stock | 411 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002099 · doc4.xml · nonDerivative · entry 2 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Forminard ElizabethExecutive VP, General Counsel
|
Exercise / conversionCommon Stock | 2,448 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002099 · doc4.xml · nonDerivative · entry 1 Forminard Elizabeth · CIK 0001950802 · Executive VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionPerformance Share Units · Derivative | 7,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002100 · doc4.xml · derivative · entry 4 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,647 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Hait WilliamSee Remarks
|
Tax withholdingCommon Stock | 4,076 | $157.40 | $641,562.40 |
DisclosureSEC source: 0001225208-24-002100 · doc4.xml · nonDerivative · entry 3 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,240 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionCommon Stock | 1,285 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002100 · doc4.xml · nonDerivative · entry 2 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Hait WilliamSee Remarks
|
Exercise / conversionCommon Stock | 7,647 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002100 · doc4.xml · nonDerivative · entry 1 Hait William · CIK 0001904791 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionPerformance Share Units · Derivative | 4,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002101 · doc4.xml · derivative · entry 6 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,911 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Tax withholdingCommon Stock | 2,887 | $157.40 | $454,413.80 |
DisclosureSEC source: 0001225208-24-002101 · doc4.xml · nonDerivative · entry 3 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,791 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 825 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002101 · doc4.xml · nonDerivative · entry 2 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,678 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Schmid TimothyEVP, WW Chair, MedTech
|
Exercise / conversionCommon Stock | 4,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002101 · doc4.xml · nonDerivative · entry 1 Schmid Timothy · CIK 0001998491 · EVP, WW Chair, MedTech 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,853 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionPerformance Share Units · Derivative | 4,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002102 · doc4.xml · derivative · entry 4 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Swanson James D.EVP, CIO
|
Tax withholdingCommon Stock | 1,695 | $157.40 | $266,793.00 |
DisclosureSEC source: 0001225208-24-002102 · doc4.xml · nonDerivative · entry 3 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,318 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionCommon Stock | 785 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002102 · doc4.xml · nonDerivative · entry 2 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,013 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Shares earned due to performance factor of 116.8% upon certification of performance results by the Board. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Swanson James D.EVP, CIO
|
Exercise / conversionCommon Stock | 4,671 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002102 · doc4.xml · nonDerivative · entry 1 Swanson James D. · CIK 0001904785 · EVP, CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 23:36 UTC |
Taubert Jennifer LEVP, WWC. Innovative Medicine
|
Exercise / conversionPerformance Share Units · Derivative | 22,433 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002103 · doc4.xml · derivative · entry 4 Taubert Jennifer L · CIK 0001745938 · EVP, WWC. Innovative Medicine 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 22,433 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.exercise_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 8, 2021; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board on February 12, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.